Literature DB >> 22281264

Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs.

M J Barter1, C Bui1, D A Young2.   

Abstract

Osteoarthritis (OA) is a complex multifactorial disease with a strong genetic component. Several studies have suggested or identified epigenetic events that may play a role in OA progression and the gene expression changes observed in diseased cartilage. The aim of this review is to inform about current research in epigenetics and epigenetics in OA. Epigenetic mechanisms include DNA methylation, histone modifications, and microRNAs. Collectively, these enable the cell to respond quickly to environmental changes and can be inherited during cell division. However, aberrant epigenetic modifications are associated with a number of pathological conditions, including OA. Advancements in epigenetic research suggests that global analysis of such modifications in OA are now possible, however, with the exception of microRNAs, it will be a significant challenge to demonstrate how such events impact on the disease.
Copyright © 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281264     DOI: 10.1016/j.joca.2011.12.012

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  59 in total

1.  DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism.

Authors:  Jie Shen; Cuicui Wang; Daofeng Li; Taotao Xu; Jason Myers; John M Ashton; Ting Wang; Michael J Zuscik; Audrey McAlinden; Regis J O'Keefe
Journal:  JCI Insight       Date:  2017-06-15

Review 2.  Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.

Authors:  Jonathan A R Gordon; Martin A Montecino; Rami I Aqeilan; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

Review 3.  The evolving role of biomarkers for osteoarthritis.

Authors:  Muneaki Ishijima; Haruka Kaneko; Kazuo Kaneko
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

4.  Characterization of DNA methylation variations during fruit development and ripening of Vitis vinifera (cv. 'Fujiminori').

Authors:  Lingfei Shangguan; Xiang Fang; Haifeng Jia; Mengxia Chen; Kekun Zhang; Jinggui Fang
Journal:  Physiol Mol Biol Plants       Date:  2020-02-03

5.  Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing.

Authors:  Dongying Li; Bridgett Knox; Binsheng Gong; Si Chen; Lei Guo; Zhichao Liu; Weida Tong; Baitang Ning
Journal:  Toxicol Sci       Date:  2021-01-06       Impact factor: 4.849

6.  In Vitro Effects of Cetylated Fatty Acids Mixture from Celadrin on Chondrogenesis and Inflammation with Impact on Osteoarthritis.

Authors:  Ariana Hudita; Bianca Galateanu; Sorina Dinescu; Marieta Costache; Anca Dinischiotu; Carolina Negrei; Miriana Stan; Aristidis Tsatsakis; Dragana Nikitovic; Dumitru Lupuliasa; Andra Balanescu
Journal:  Cartilage       Date:  2018-05-29       Impact factor: 4.634

7.  Microfluidic MeDIP-seq for low-input methylomic analysis of mammary tumorigenesis in mice.

Authors:  Yan Zhu; Zhenning Cao; Chang Lu
Journal:  Analyst       Date:  2019-03-11       Impact factor: 4.616

Review 8.  Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.

Authors:  Jingting Li; James Ohliger; Ming Pei
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

9.  The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis.

Authors:  Paolo Santini; Laura Politi; Pietro Dalla Vedova; Roberto Scandurra; Anna Scotto d'Abusco
Journal:  Rheumatol Int       Date:  2013-04-18       Impact factor: 2.631

Review 10.  Epigenetics advancing personalized nanomedicine in cancer therapy.

Authors:  Shujun Liu
Journal:  Adv Drug Deliv Rev       Date:  2012-08-19       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.